PBRM1 and nonpapillary renal cell carcinoma: Among the screen, we identified 5-Fluoro-2′-deoxycytidine (FdCyd), a DNA methyltransferase inhibitors (DNMTi) as synthetic lethality drugs for PBRM1-deficient ccRCC cells.